0 Datasets
0 Files
Get instant academic access to this publication’s datasets.
Yes. After verification, you can browse and download datasets at no cost. Some premium assets may require author approval.
Files are stored on encrypted storage. Access is restricted to verified users and all downloads are logged.
Yes, message the author after sign-up to request supplementary files or replication code.
Join 50,000+ researchers worldwide. Get instant access to peer-reviewed datasets, advanced analytics, and global collaboration tools.
✓ Immediate verification • ✓ Free institutional access • ✓ Global collaborationJoin our academic network to download verified datasets and collaborate with researchers worldwide.
Get Free AccessFor NF1-GISTs <30 mm, prognosis without relapse is excellent. RECKGIST score accurately predicts recurrence and needs to be validated in an external cohort, but it may help treatment decision making. No efficacy of adjuvant treatment was observed.
Claude Cuvelier, Mehdi Brahmi, Iradj Sobhani, B. Verret, Adrien Grancher, Nicolas Penel, Maud Toulmonde, W. Lahlou, H. Dupuis, Laura Calavas, Marie Müller, Sarah Watson, Damien Bruyat, François Poumeaud, L. Chaigneau, Sylvain Manfrédi, Thierry Lecomte, F. Bertucci, François Ghiringhelli, Marc Pracht, Farouk Mourthadhoi, Lucie Monceau-Baroux, Morgane Helyon, Jean‐Emmanuel Kurtz, Guillaume Roquin, Nicolas Régenet, Marie Vinches, David Tougeron, P. Wolkenstein, Jean Yves Blay, Olivier Bouché, Vincent Hautefeuille (2025). Clinical description and development of a prognostic score for neurofibromatosis type 1 (NF1)-associated GISTs: a retrospective study from the NETSARC+. , 10(3), DOI: https://doi.org/10.1016/j.esmoop.2025.104477.
Datasets shared by verified academics with rich metadata and previews.
Authors choose access levels; downloads are logged for transparency.
Students and faculty get instant access after verification.
Type
Article
Year
2025
Authors
32
Datasets
0
Total Files
0
Language
en
DOI
https://doi.org/10.1016/j.esmoop.2025.104477
Access datasets from 50,000+ researchers worldwide with institutional verification.
Get Free Access
